Literature DB >> 21125662

Activation of CD47 receptors causes proliferation of human astrocytoma but not normal astrocytes via an Akt-dependent pathway.

Emilie Sick1, Abdelaziz Boukhari, Thérèse Deramaudt, Philippe Rondé, Bernard Bucher, Philippe André, Jean-Pierre Gies, Kenneth Takeda.   

Abstract

CD47 is a membrane receptor that plays pivotal roles in many pathophysiological processes, including infection, inflammation, cell spreading, proliferation, and apoptosis. We show that activation of CD47 increases proliferation of human U87 and U373 astrocytoma cells but not normal astrocytes. CD47 function-blocking antibodies inhibit proliferation of untreated U87 and U373 cells but not normal astrocytes, suggesting that CD47 may be constitutively activated in astrocytoma. CD47 expression levels were similar in our three cell types. CD47 couples to G-proteins in astrocytes and astrocytoma and especially to the Gβγ dimer. Downstream signaling following CD47 activation involves Gβγ dimer-dependent activation of the PI3K/Akt pathway in astrocytoma cells but not in normal astrocytes. This pathway is known to be deregulated in astrocytoma, leading to cell proliferation and enhanced survival signals. Putative PLIC-1 interaction with CD47 in astrocytoma cells but not astrocytes may contribute to the proliferative effect observed upon activation of CD47. Our data indicate that CD47 receptors have a stimulatory role in cell proliferation and demonstrate for the first time that CD47 signals via the PI3K/Akt pathway in cancerous cells but not normal cells.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21125662     DOI: 10.1002/glia.21102

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  28 in total

Review 1.  CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest.

Authors:  E Sick; A Jeanne; C Schneider; S Dedieu; K Takeda; L Martiny
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

2.  Amyloid-β-induced astrocytic phagocytosis is mediated by CD36, CD47 and RAGE.

Authors:  Raasay S Jones; Aedín M Minogue; Thomas J Connor; Marina A Lynch
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-14       Impact factor: 4.147

Review 3.  Divergent modulation of normal and neoplastic stem cells by thrombospondin-1 and CD47 signaling.

Authors:  Sukhbir Kaur; David D Roberts
Journal:  Int J Biochem Cell Biol       Date:  2016-05-06       Impact factor: 5.085

4.  Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma.

Authors:  Lei Wu; Guang-Tao Yu; Wei-Wei Deng; Liang Mao; Lei-Lei Yang; Si-Rui Ma; Lin-Lin Bu; Ashok B Kulkarni; Wen-Feng Zhang; Lu Zhang; Zhi-Jun Sun
Journal:  Oncoimmunology       Date:  2018-03-13       Impact factor: 8.110

5.  Thrombospondin-targeting TAX2 peptide impairs tumor growth in preclinical mouse models of childhood neuroblastoma.

Authors:  Albin Jeanne; Laurent Martiny; Stéphane Dedieu
Journal:  Pediatr Res       Date:  2016-11-14       Impact factor: 3.756

Review 6.  CD47 signaling pathways controlling cellular differentiation and responses to stress.

Authors:  David R Soto-Pantoja; Sukhbir Kaur; David D Roberts
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-02-24       Impact factor: 8.250

7.  Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis.

Authors:  Yuhua Wang; Zhenghong Xu; Shutao Guo; Lu Zhang; Arati Sharma; Gavin P Robertson; Leaf Huang
Journal:  Mol Ther       Date:  2013-06-18       Impact factor: 11.454

Review 8.  Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.

Authors:  Tiantian Guo; Denghong Zhang; Yuzhe Zeng; Timothy Y Huang; Huaxi Xu; Yingjun Zhao
Journal:  Mol Neurodegener       Date:  2020-07-16       Impact factor: 14.195

9.  Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47.

Authors:  Hiroaki Kamijo; Tomomitsu Miyagaki; Naomi Takahashi-Shishido; Rina Nakajima; Tomonori Oka; Hiraku Suga; Makoto Sugaya; Shinichi Sato
Journal:  Leukemia       Date:  2019-11-11       Impact factor: 11.528

10.  Overexpression of CD47 predicts poor prognosis and promotes cancer cell invasion in high-grade serous ovarian carcinoma.

Authors:  Yinuo Li; Shuhua Lu; Ying Xu; Chunping Qiu; Chengjuan Jin; Yuqiong Wang; Zhaojian Liu; Beihua Kong
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.